Audentes Therapeutics, Inc., An Astellas Company

Today is World Duchenne Awareness Day! There are many ways to get involved - for instance Jett Foundation is holding a virtual celebration all week check out how you can help raise awareness: https://www.jettfoundation.org/wdad #WDAD20 #DMD

Hear how our employees personally identify with our company values of care deeply, be bold (find a way) and get stuff done:

Check it out! Our CEO was named as one of the top 100 "commanders & chiefs" in the industry by PharmaVOICE. You can read more about Natalie’s passion for the work we are doing to drive #genetherapy forward: https://bit.ly/33lvxEP

Audentes Therapeutics to Participate in Upcoming Investor Conferences: https://bit.ly/2Yts7Pi

Audentes Announces Upcoming Presentations at the 24th International Annual Congress of the World Muscle Society, Including New Data from ASPIRO: https://bit.ly/2Yts7Pi

Audentes Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update: https://bit.ly/2Yts7Pi

Audentes Therapeutics to Participate in Upcoming Investor Conferences: https://bit.ly/2V6nWnl

Audentes Therapeutics to Release Second Quarter 2019 Financial Results and Provide Corporate Update on Tuesday, August 6, 2019: https://bit.ly/2V6nWnl

Audentes Therapeutics Announces Changes to Senior Management Team: https://bit.ly/2wrrZzh

Audentes Therapeutics to Participate in the Bank of America Merrill Lynch 2019 Health Care Conference: https://bit.ly/2V6nWnl

Audentes Therapeutics Announces Expansion of AAV Technology Platform and Pipeline with New Development Programs for Duchenne Muscular Dystrophy and Myotonic Dystrophy: https://bit.ly/2YWEn7p